EMPA-RESPONSE

Randomized, double blind, placebo controlled, multicenter pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure

Stadium: klaar
Middel: empagliflozin
Populatie: Hartfalen
Fase: II
First Patient In: 1 december 2017
Last Patient In: -
Last Patient Last Visit: -

National Lead

prof. dr. A. Voors

Cardioloog